Carcinogenesis Advance Access published online on March 14, 2006
Carcinogenesis, doi:10.1093/carcin/bgi370
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Food Science and Human Nutrition, University of Illinois, 905 S Goodwin, Room 580 Bevier Hall, Urbana, IL; Current Address: 325 Wallace Hall Department of Human Nutrition, Foods and Exercise, Virginia Polytechnic and State University, Blacksburg, Virginia 24061
* To whom correspondence should be addressed. We have demonstrated that genistein (GEN) stimulates growth of estrogen-dependent breast tumors in vivo. In this study, we evaluated whether dietary GEN can act in an additive manner with low circulating levels of 17 1Supported by CA77355 and AG024387; Y.H.J. received postdoctoral support from the National Institutes of Environment, Health and Science Training Program Grant PHS T32 ES07326 5 AIN93G: American Institute of Nutrition 93 growth semi-purified diet, BCS: bovine calf serum, CD-BCS: charcoal-dextran stripped BCS, E2:17
Received August 26, 2005
Revised January 3, 2006
Accepted February 6, 2006
CARCINOGENESIS
Genistein stimulates growth of human breast cancer cells in a novel, postmenopausal animal model, with low plasma estradiol concentrations1
Young H. Ju 1,
Kimberly F. Allred 2,
Clinton D. Allred 2,
and
William G. Helferich 3 *
2 Department of Food Science and Human Nutrition, University of Illinois, 905 S Goodwin, Room 580 Bevier Hall, Urbana, IL; Current Address: Department of Physiology, University of Kentucky, Lexington KY 40536
3 Department of Food Science and Human Nutrition, University of Illinois, 905 S Goodwin, Room 580 Bevier Hall, Urbana, IL
William G. Helferich, E-mail: helferic{at}uiuc.edu
![]()
Abstract
-estradiol (E2)5. We developed an E2 delivery system using silastic implants that yield low circulating plasma E2 levels similar to those observed in postmenopausal women. We inserted various concentrations of E2 silastic implants (1:127, 1:63, 1:31, 1:15, and 1:7 = E2:cholesterol) and injected estrogen-dependent human breast cancer (MCF-7) cells into ovariectomized athymic mice. The E2 implants tested (1:127 - 1:7) generated 30.1-101.6 pM E2 in plasma, which is comparable to the E2 levels observed in postmenopausal women. The E2 implants stimulated MCF-7 tumor growth in a dose dependent manner. We selected the 1:31 ratio of E2 implant to evaluate if dietary GEN acts in an additive manner with low E2 levels to influence the growth of MCF-7 tumors. Ovariectomized mice were divided into four groups: MCF-7 control, 500 ppm GEN, 1:31 E2, and 1:31 E2 + 500 ppm GEN. At week 17, the average tumor sizes were 7.6 mm2, 32.1 mm2, 67.4 mm2, and 106.8 mm2 for these groups, respectively (p<0.05), demonstrating that 500 ppm GEN additively stimulated MCF-7 tumor growth in the presence of low levels of E2. In summary, we established a pre-clinical mouse model that results in E2 blood concentrations similar to those found in postmenopausal women. Further, we observed that these concentrations regulate the growth rate of MCF-7 breast tumors. Using this model, we demonstrated that dietary GEN in the presence of low levels of circulating E2 act in an additive manner to stimulate estrogen-dependent tumor growth in vivo. Results from this study suggest that consumption of products containing GEN may not be safe for postmenopausal women with estrogen-dependent breast cancer.
-estradiol, ER: estrogen receptor, MCF-7: Michigan Cancer Foundation-7, MEM: minimal essential media, qRT-PCR: reverse transcription polymerase chain reaction, RIA: radioimmunoassay, SEM: standard error of mean![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Iwasaki, M. Inoue, T. Otani, S. Sasazuki, N. Kurahashi, T. Miura, S. Yamamoto, and S. Tsugane Plasma Isoflavone Level and Subsequent Risk of Breast Cancer Among Japanese Women: A Nested Case-Control Study From the Japan Public Health Center-Based Prospective Study Group J. Clin. Oncol., April 1, 2008; 26(10): 1677 - 1683. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Chau, L. H. El Touny, S. Jagadeesh, and P. P. Banerjee Physiologically achievable concentrations of genistein enhance telomerase activity in prostate cancer cells via the activation of STAT3 Carcinogenesis, November 1, 2007; 28(11): 2282 - 2290. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Duffy, K. Perez, and A. Partridge Implications of Phytoestrogen Intake for Breast Cancer CA Cancer J Clin, September 1, 2007; 57(5): 260 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bergman Jungestrom, L. U. Thompson, and C. Dabrosin Flaxseed and Its Lignans Inhibit Estradiol-Induced Growth, Angiogenesis, and Secretion of Vascular Endothelial Growth Factor in Human Breast Cancer Xenografts In vivo Clin. Cancer Res., February 1, 2007; 13(3): 1061 - 1067. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Messina, W. McCaskill-Stevens, and J. W. Lampe Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings. J Natl Cancer Inst, September 20, 2006; 98(18): 1275 - 1284. [Abstract] [Full Text] [PDF] |
||||




